Researchers leading the Dominantly Inherited Alzheimer's Network (DIAN) recently announced that two pharmaceutical companies have agreed to donate investigational drugs to use in side by side trials in people who are destined by genetics to develop early-onset Alzheimer's disease. The companies have agreed to at least partially fund a five-year therapy trial, as well.
Read more about Alzheimer's drug trial:
Purchase Minding Our Elders: Caregivers Share Their Personal Stories – paperback or ebook





Comments